thymoquinone has been researched along with Cancer of Colon in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvizu-Espinosa, MG; Estrada-Meza, C; Osorio-Pérez, SM; Paul, S; Ruiz-Manriquez, LM; Sharma, A; Srivastava, A | 1 |
| Awad, GAS; Metwally, AA; Nasr, M; Ramzy, L | 1 |
| Kapoor, VK; Malik, S; Negi, P; Singh, A | 1 |
| Choi, BY; Chun, KS; Jeong, CH; Kundu, J; Kundu, JK | 1 |
| Chen, LM; Chen, MC; Ho, TJ; Hsieh, DJ; Hsu, HH; Huang, CY; Kuo, WW; Lee, NH; Lin, YM; Tu, CC | 1 |
| Agbaria, R; Ben-Shabat, S; Dahan, A; Gabarin, A | 1 |
| Chen, MC; Chen, RJ; Ho, TJ; Hsu, HH; Huang, CY; Kuo, WW; Lee, NH; Lin, YM; Tu, CC; Viswanadha, VP | 1 |
| Ahmad, J; El-Shemi, AG; Idris, S; Kensara, OA; Mohamed, AM; Refaat, B | 1 |
| El-Baba, C; Fatfat, M; Fröhlich, T; Gali-Muhtasib, H; Hofmeister, E; Mederer, S; Muenzner, JK; Ndreshkjana, B; Reiter, C; Schneider-Stock, R; Tsogoeva, SB | 1 |
| Chen, MC; Day, CH; Hsu, HH; Huang, CY; Kuo, WW; Li, SY; Lin, YM; Padma, VV; Shih, HN; Tu, CC | 1 |
| Chatila, M; El-Najjar, N; Gali-Muhtasib, H; Gandesiri, M; Moukadem, H; Ocker, M; Schneider-Stock, R; Vuorela, H | 1 |
| Grayaa, R; Hammami, M; Harzallah, HJ; Kharoubi, W; Maaloul, A; Mahjoub, T | 1 |
| Almawi, WY; Ben-Hadj-Khalifa, S; Houas, Z; Jrah-Harzallah, H; Maaloul, A; Mahjoub, T | 1 |
| Benghuzzi, H; May, M; Norwood, AA; Tan, M; Tucci, M | 1 |
| Benghuzzi, H; Norwood, AA; Tucci, M | 1 |
1 review(s) available for thymoquinone and Cancer of Colon
| Article | Year |
|---|---|
Thymoquinone: A small molecule from nature with high therapeutic potential.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Biological Availability; Breast Neoplasms; Carcinoma, Hepatocellular; Cardiomyopathies; Colonic Neoplasms; Diabetes Mellitus, Type 2; Humans; Liver Neoplasms; Nanoparticle Drug Delivery System; Neoplasms; Nervous System Diseases | 2021 |
14 other study(ies) available for thymoquinone and Cancer of Colon
| Article | Year |
|---|---|
Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells.
Topics: Cell Line, Tumor; Colonic Neoplasms; Humans; Male; MicroRNAs; PC-3 Cells; Prostate; Prostatic Neoplasms | 2023 |
Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors.
Topics: Benzamides; Benzoquinones; Caco-2 Cells; Cell Proliferation; Cell Survival; Colonic Neoplasms; Delayed-Action Preparations; HCT116 Cells; HT29 Cells; Humans; Nanocapsules; Particle Size; Polymethacrylic Acids; Receptors, sigma | 2020 |
Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
Topics: Apoptosis; Benzoquinones; Cell Proliferation; Colonic Neoplasms; CSK Tyrosine-Protein Kinase; ErbB Receptors; HCT116 Cells; Humans; Janus Kinase 2; Phosphorylation; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor | 2014 |
Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38.
Topics: Apoptosis; Autophagy; Benzoquinones; Caspases; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; JNK Mitogen-Activated Protein Kinases; Mitochondria; Nigella sativa; p38 Mitogen-Activated Protein Kinases; Plant Extracts | 2015 |
Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Stability; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Hot Temperature; Mice; NF-kappa B; Nigella sativa; Phytotherapy; Plant Extracts; Plant Oils; Plants, Medicinal; Seeds; Time Factors; Transcription, Genetic; Transfection | 2015 |
Inhibition of NF-κB and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Camptothecin; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Irinotecan; JNK Mitogen-Activated Protein Kinases; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Transcription Factor RelA | 2017 |
Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Benzoquinones; Carcinogenesis; Cell Proliferation; Colonic Neoplasms; Fluorouracil; Male; Rats, Wistar | 2016 |
Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer.
Topics: Antineoplastic Agents; Artemisinins; Benzoquinones; Cell Survival; Colonic Neoplasms; HCT116 Cells; Histones; HT29 Cells; Humans; Reactive Oxygen Species | 2017 |
Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Phytochemicals; Signal Transduction | 2017 |
Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Oxidative Stress; Reactive Oxygen Species | 2010 |
Thymoquinone, the Nigella sativa bioactive compound, prevents circulatory oxidative stress caused by 1,2-dimethylhydrazine in erythrocyte during colon postinitiation carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Benzoquinones; Catalase; Cell Transformation, Neoplastic; Colonic Neoplasms; Erythrocytes; Glutathione Peroxidase; Hematocrit; Hemoglobins; Lipid Peroxidation; Male; Malondialdehyde; Nigella sativa; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2012 |
Effect of thymoquinone on 1,2-dimethyl-hydrazine-induced oxidative stress during initiation and promotion of colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antioxidants; Benzoquinones; Body Weight; Carcinogens; Carcinoma; Cell Transformation, Neoplastic; Colonic Neoplasms; Drug Evaluation, Preclinical; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species | 2013 |
Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells.
Topics: Antineoplastic Agents; Benzoquinones; Catechin; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Feasibility Studies; Fluorouracil; Plant Extracts; Tea; Treatment Outcome | 2006 |
A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzoquinones; Catechin; Cell Proliferation; Cell Survival; Colonic Neoplasms; Delayed-Action Preparations; Dose-Response Relationship, Drug; Fluorouracil; Humans; Phytotherapy; Plant Extracts; Treatment Outcome; Tumor Cells, Cultured | 2007 |